Patents by Inventor Olga Ordeig
Olga Ordeig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11779919Abstract: A microfluidic system includes a microfluidic cartridge and a detector assembly. The microfluidic cartridge includes a first and second side and at least one flow channel and an inlet to flow channel(s) for feeding a liquid sample, the flow channel(s) includes a plurality of first optical detection sites. The detector assembly includes a slot. The detector assembly and the microfluidic cartridge are constructed such that when the microfluidic cartridge is inserted to a first predetermined position into the slot, one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source, and when the cartridge is inserted to a second predetermined position into the slot, another one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source.Type: GrantFiled: March 13, 2019Date of Patent: October 10, 2023Assignee: ZOETIS DENMARK APSInventors: Niels Kristian Bau-Madsen, Lars Bue Nielsen, Martin Heller, Ole Kring, Olga Ordeig, Bent Overby
-
Publication number: 20190210022Abstract: A microfluidic system includes a microfluidic cartridge and a detector assembly. The microfluidic cartridge includes a first and second side and at least one flow channel and an inlet to flow channel(s) for feeding a liquid sample, the flow channel(s) includes a plurality of first optical detection sites. The detector assembly includes a slot. The detector assembly and the microfluidic cartridge are constructed such that when the microfluidic cartridge is inserted to a first predetermined position into the slot, one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source, and when the cartridge is inserted to a second predetermined position into the slot, another one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source.Type: ApplicationFiled: March 13, 2019Publication date: July 11, 2019Applicant: SCANDINAVIAN MICRO BIODEVICES APSInventors: Niels Kristian Bau-Madsen, Lars Bue Nielsen, Martin Heller, Ole Kring, Olga Ordeig, Bent Overby
-
Patent number: 10307754Abstract: A microfluidic cartridge includes first and second sides and at least one flow channel and an inlet to the flow channel(s) for feeding a liquid sample, the flow channel(s) include a plurality of first optical detection sites. A detector assembly includes a slot for inserting the microfluidic cartridge and a first fixed light source with a beam path and an optical reader for reading out optical signals from at least one of the first optical detection site(s). When the microfluidic cartridge is inserted to a first predetermined position into the slot, one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source, and when the cartridge is inserted to a second predetermined position into the slot, another one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source.Type: GrantFiled: June 15, 2015Date of Patent: June 4, 2019Assignee: SCANDINAVIAN MICRO BIODEVICES APSInventors: Niels Kristian Bau-Madsen, Lars Bue Nielsen, Martin Heller, Ole Kring, Olga Ordeig, Bent Overby
-
Patent number: 9907906Abstract: MicroElectroMechanical System (MEMS) devices can be fabricated completely of hydrogel materials. Such hydrogels can include polyethylene glycol with diacrylate functional groups (e.g., PEGDA), which are photopolymerizable in the presence of crosslinkers and photoinitiators. By using PEGDA monomers of different molecular weights and at different percentages, the mechanical properties of the polymerized gels and their respective permeabilities can be tuned. This spatial variation in properties and permeabilities can lead to different functionalities between different portions of the hydrogel MEMS device. Portions of the hydrogel device may be remotely actuated by applying wave energy, for example, a magnetic field, high intensity focused ultrasound, and/or infrared radiation. The remote actuation can allow the device to be actuated in vivo, for example, to allow the device to deliver a drug or other substance at a desired time and/or desired location within a patient.Type: GrantFiled: July 29, 2013Date of Patent: March 6, 2018Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Olga Ordeig, Samuel K. Sia, Sau Yin Chin, Anne-Celine Kohler, Yuk Kee Cheung Poh
-
Publication number: 20170203295Abstract: A microfluidic cartridge includes first and second sides and at least one flow channel and an inlet to the flow channel(s) for feeding a liquid sample, the flow channel(s) include a plurality of first optical detection sites. A detector assembly includes a slot for inserting the microfluidic cartridge and a first fixed light source with a beam path and an optical reader for reading out optical signals from at least one of the first optical detection site(s). When the microfluidic cartridge is inserted to a first predetermined position into the slot, one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source, and when the cartridge is inserted to a second predetermined position into the slot, another one of the first optical detection sites of the microfluidic cartridge is positioned in the beam path of the first light source.Type: ApplicationFiled: June 15, 2015Publication date: July 20, 2017Applicant: SCANDINAVIAN MICRO BIODEVICES APSInventors: Niels Kristian BAU-MADSEN, Lars Bue NIELSEN, Martin HELLER, Ole KRING, Olga ORDEIG, Bent OVERBY
-
Publication number: 20140031750Abstract: MicroElectroMechanical System (MEMS) devices can be fabricated completely of hydrogel materials. Such hydrogels can include polyethylene glycol with diacrylate functional groups (e.g., PEGDA), which are photopolymerizable in the presence of crosslinkers and photoinitiators. By using PEGDA monomers of different molecular weights and at different percentages, the mechanical properties of the polymerized gels and their respective permeabilities can be tuned. This spatial variation in properties and permeabilities can lead to different functionalities between different portions of the hydrogel MEMS device. Portions of the hydrogel device may be remotely actuated by applying wave energy, for example, a magnetic field, high intensity focused ultrasound, and/or infrared radiation. The remote actuation can allow the device to be actuated in vivo, for example, to allow the device to deliver a drug or other substance at a desired time and/or desired location within a patient.Type: ApplicationFiled: July 29, 2013Publication date: January 30, 2014Applicant: The Trustees of Columbia University in the City of New YorkInventors: OLGA ORDEIG, SAMUEL K. SIA, SAU YIN CHIN, ANNE-CELINE KOHLER, YUK KEE CHEUNG POH
-
Publication number: 20130030354Abstract: MicroElectroMechanical System (MEMS) devices can be fabricated completely of hydrogel materials. Such hydrogels can include polyethylene glycol with diacrylate functional groups (e.g., PEGDA), which are photopolymerizable in the presence of crosslinkers and photoinitiators. By using PEGDA monomers of different molecular weights and at different percentages, the mechanical properties of the polymerized gels and their respective permeabilities can be tuned. This spatial variation in properties and permeabilities can lead to different functionalities between different portions of the hydrogel MEMS device. Portions of the hydrogel device may be remotely actuated by applying wave energy, for example, a magnetic field, high intensity focused ultrasound, and/or infrared radiation. The remote actuation can allow the device to be actuated in vivo, for example, to allow the device to deliver a drug or other substance at a desired time and/or desired location within a patient.Type: ApplicationFiled: July 27, 2012Publication date: January 31, 2013Applicant: The Trustees of Columbia University in the City of New YorkInventors: Sau Yin CHIN, Samuel K. Sia, Olga Ordeig, Anne-Celine Kohler, Yuk Kee Cheung